[Isolation of Geosmithia argillacea in a cystic fibrosis patient]

F Labbé1, S Babchia, F Evreux

  • 1Laboratoire de microbiologie, hôpital J. Monod, groupe hospitalier du Havre, Le Havre cedex, France. franck.labbe@ch-havre.fr

Insights

Geosmithia argillacea, a newly identified fungus, was found in an 11-year-old cystic fibrosis patient. While not causing illness in this case, this mold is an emerging threat in cystic fibrosis.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Cystic fibrosis (CF) is a genetic disorder affecting lungs and other organs.
  • Emerging fungal infections pose a growing concern in immunocompromised individuals.
  • Geosmithia argillacea is a filamentous fungus recently identified as an emergent pathogen.

Observation:

  • An 11-year-old child diagnosed with cystic fibrosis had Geosmithia argillacea isolated from sputum samples.
  • The presence of G. argillacea in this patient was not associated with any discernible clinical symptoms or disease exacerbation.
  • This case contributes to the understanding of fungal colonization in cystic fibrosis patients.

Findings:

  • Geosmithia argillacea can colonize the respiratory tract of cystic fibrosis patients.
  • The fungus was identified in sputum, indicating its presence within the pulmonary system.
  • Clinical significance of G. argillacea in CF patients requires further investigation.

Implications:

  • While G. argillacea did not cause disease in this pediatric CF case, it has been linked to severe invasive infections in other contexts.
  • This finding highlights the importance of monitoring for emerging fungal pathogens in cystic fibrosis.
  • Further research is needed to determine the pathogenic potential and clinical management strategies for G. argillacea in CF and other vulnerable populations, including those with chronic granulomatous disease or post-lung transplantation.